Heart Failure and Comorbidities—Part 1

The main objective of the 1st part of this review is to demonstrate that a better understanding of comorbidities such as COPD, obstructive sleep apnea, thyroid dysfunction, cardiorenal syndrome, its pathophysiological and therapeutic implications, impact on the management of FH by interfering with its survival, and quality of life of patients. The prevalence of heart failure will increase 46% from 2012 to 2030, resulting in > 8 million people...